The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Novartis
Travel, Accommodations, Expenses - Pfizer
Association between type of BRCA1/2 pathogenic/likely pathogenic variants and outcome in young patients with breast cancer: Results from an international cohort study.
 
Angela Toss
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences
 
Eva Blondeaux
Honoraria - Lilly
Research Funding - Gilead Sciences
 
Elena Tenedini
Travel, Accommodations, Expenses - SOPHiA Genetics
 
Lia Bonamici
No Relationships to Disclose
 
Rossella Graffeo
No Relationships to Disclose
 
Luca Livraghi
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Italfarmaco; Pfizer
 
Cynthia Villarreal-Garza
Honoraria - Lilly; MSD; Novartis; Pfizer
Consulting or Advisory Role - Amplity Health; Lilly; MSD; Novartis
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - MSD; Pfizer
 
Rinat Bernstein-Molho
No Relationships to Disclose
 
Ava Kwong
Honoraria - AstraZeneca/UK; Pfizer; Stryker Roche
Research Funding - AstraZeneca/UK (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Judith Balmaña
Honoraria - AstraZeneca
 
Hans Wildiers
Consulting or Advisory Role - Agendia (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); MediMix bv (Inst); Menarini (Inst); Novartis (Inst); NV Hict (Inst); Pfizer (Inst); PSI (Inst); Roche (Inst); Seagen (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst)
 
Elisa Agostinetto
Honoraria - Abscint (Inst); AstraZeneca; Lilly
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abscint; AstraZeneca; AstraZeneca; Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
Kelly-Anne Phillips
Research Funding - AstraZeneca (Inst)
 
Katarzyna Pogoda
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Sandoz
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly Poland; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Tiphaine Renaud
No Relationships to Disclose
 
Christine Rousset-Jablonski
Honoraria - Thramex (Inst)
Consulting or Advisory Role - Bristol Myers Squibb; Gédéon Richter (Inst); Roche (Inst); Theramex (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
Research Funding - Bayer (Inst); Gédéon Richter (Inst)
Travel, Accommodations, Expenses - Gédéon Richter
 
Alberta Ferrari
Consulting or Advisory Role - AstraZeneca; MSD
 
Virginia Delucchi
No Relationships to Disclose
 
Carmine De Angelis
Honoraria - Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca/UK; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; Seagen
Research Funding - Daiichi Sankyo (Inst); Gilead Sciences (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche